STERIS plc (Ireland) Ordinary Shares (STE)

STERIS delivered a quarter that met Wall Street’s expectations, driven by strong underlying demand in its Healthcare and Life Sciences segments, as well as a...

Restructuring charges and a pending Xodus Medical deal headline a strong quarter.

Medical equipment and services company Steris (NYSE:STE) announced better-than-expected revenue in calendar Q3 2026 (fiscal Q2 2027), with revenue up 8.8% ye...

What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat...

Medical equipment and services company Steris (NYSE:STE) will be announcing earnings results this Wednesday after the bell. Here’s what you need to know. STE...

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have...

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

An official report on August 27, 2026 reveals Representative Jared Moskowitz's recent sale of Steris (NYSE:STE) stock, valued between $2,002 and $30,000. The transaction took place on July 13, 2026, as per the

Over the past six months, STERIS’s shares (currently trading at $232.53) have posted a disappointing 7.4% loss, well below the S&P 500’s 12.9% gain. This mig...

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how surgical equipment & c...

STERIS (NYSE:STE) reported first-quarter fiscal 2027 revenue growth and higher earnings, while maintaining its full-year outlook and outlining a $600 million investment in a new chemistry manufacturing, research and distribution complex in North Carolina. Total reported revenue increased 7% from th

Medical equipment and services company Steris (NYSE:STE) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 7.3% year on year to $1.49 billio...

Medical equipment and services company Steris (NYSE:STE) will be announcing earnings results this Wednesday after the bell. Here’s what you need to know. STE...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...

STERIS’s stock price has taken a beating over the past six months, shedding 20.4% of its value and falling to $202.39 per share. This might have investors co...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...